• No results found

Cover Page

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/137309 holds various files of this Leiden University dissertation.

Author: Wang, Z.

(2)

Exploring Grainyhead-like 2 target

genes in breast cancer

(3)

Exploring Grainyhead-like 2 target genes in breast cancer

Zi Wang, March 2020.

Zi Wang was supported by China Schorlarship Council (201506200095).

This research was carried out at the Division of Drug Discorvery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. The research was supported by the Dutch Cancer Society (grant no. 10967).

ISBN 978-94-92597-45-8 Printed by Printsupport4U, NL

Cover and lay-out of this thesis designed by Zi Wang.

© Copyright, Zi Wang, 2020.

(4)

Exploring Grainyhead-like 2 target

genes in breast cancer

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus, prof. mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op dinsday, 6 oktober 2020

klokke 10:00 uur

door

Zi Wang | 王梓

(5)

Promotor

Prof. dr. E.H.J. Danen Copromotor

Dr. J.M. Zweemer Promotiecommissie Prof. dr. H. Irth (Chair)

Leiden University, Leiden

Prof. dr. J.A. Bouwstra (Secretary)

Leiden University, Leiden

Prof. dr. B. van de Water

Leiden University, Leiden

Prof. dr. J. Martens

Erasmus University Medical Center, Rotterdam

Dr. G. van der Pluijm

(6)

Table of Contents

Chapter 1

General Introduction and outline of this thesis 1~25

Chapter 2

The role of GRHL2 in luminal- and basal like breast cancer 26~48

Chapter 3

Genome-wide identification of binding sites of GRHL2 in luminal-like and basal A subtypes of breast cancer

49~73 Chapter 4

Dynamic changes in nascent RNA after GRHL2 loss in luminal-like breast cancer 74~108

Chapter 5

Identification of direct GRHL2 target genes in luminal-like breast cancer through integration of ChIP-seq and Bru-seq

109~126 Chapter 6

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was performed at the Division of Drug Delivery Technology of the Leiden Academic Centre for Drug Research (LACDR) and at the Leiden

The research described in this thesis was performed at the Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.

The research described in this thesis was performed at the division Drug Discovery and Safety of Leiden Academic Centre for Drug Research (LACDR), Leiden.. University (Leiden,

The research described in this thesis was performed at the division of Biotherapeu- tics of the Leiden Academic Centre for Drug Research (LACDR), Leiden University (Leiden,

The research described in this thesis was performed at the Leiden University Medical Center, the Leiden Academic Center for Drug Research and the Centre for Human Drug Research and

The research described in this thesis was performed at the department of Medicinal Chemistry of the Leiden Academic Centre for Drug Research (LACDR), Leiden University (Leiden,

This research was conducted at the Division of Drug Discovery and Safety of the Leiden Academic Centre for Drug Research, Leiden University, Leiden, The

The research described in this thesis was performed at the division of Drug Discovery and Safety of the Leiden Academic Centre for Drug Research (LACDR), Leiden University, The